Madrigal Pharmaceuticals (FRA:YDO1) Ending Cash Position : €100.3 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Madrigal Pharmaceuticals Ending Cash Position?

Madrigal Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 was €100.3 Mil.

Madrigal Pharmaceuticals's quarterly Ending Cash Position declined from Jun. 2024 (€464.1 Mil) to Sep. 2024 (€214.2 Mil) and declined from Sep. 2024 (€214.2 Mil) to Dec. 2024 (€100.3 Mil).

Madrigal Pharmaceuticals's annual Ending Cash Position declined from Dec. 2022 (€313.0 Mil) to Dec. 2023 (€91.6 Mil) but then increased from Dec. 2023 (€91.6 Mil) to Dec. 2024 (€100.3 Mil).

Madrigal Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Madrigal Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Madrigal Pharmaceuticals Ending Cash Position Chart

Madrigal Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

44.39

32.10

312.98

91.62

100.29

Madrigal Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															91.62	572.72	464.13	214.15	100.29

Madrigal Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Madrigal Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	95.419	+	4.874
	=	100.3

Madrigal Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	226.988	+	-126.695
	=	100.3

Madrigal Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Madrigal Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Madrigal Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Madrigal Pharmaceuticals Inc (FRA:YDO1) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MDGL:USA 0JXI:UK YDO1:Germany

Address

200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428

Website

https://www.madrigalpharma.com

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Madrigal Pharmaceuticals Headlines

No Headlines